Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Trulieve Was the First U.S. Pure-Play Cannabis Stock on the NYSE. Here's Which Stock Could Be Next.

Another cannabis company has rising revenue, strengthening its case for an exchange listing.

Trulieve Cannabis made history as the first U.S. pure-play cannabis company to list on the New York Stock Exchange (NYSE) on June 10, marking a significant milestone for the industry. This achievement came after a major shift in federal marijuana policy, where the April 2026 decision moved state-licensed medical marijuana into Schedule III, opening doors for therapeutic drugs to trade on major exchanges. Trulieve's success prompted speculation about which other cannabis companies might follow suit.

Green Thumb Industries (GTBIF), one of the largest cannabis operators in the country, is a potential candidate for a major NYSE listing. The company boasts impressive financial metrics, including $324.4 million in revenue, an 11% year-over-year increase, and normalized EBITDA of $89.4 million, representing a 27.6% margin. Moreover, Green Thumb generated $58.3 million in operating cash flow and holds $316 million in cash reserves, demonstrating financial stability.

However, Green Thumb faces regulatory challenges and hasn't announced an uplisting plan. Unlike Trulieve, which operates solely in the medical cannabis market post-structure, Green Thumb continues to serve both recreational and medical customers, complicating its path to a regulated listing. Despite these hurdles, the company has been returning capital to shareholders through a stock repurchase program, buying back about 29.5 million shares at a cost of $203.4 million since 2023.

If federal cannabis reforms continue and major exchanges become more accessible to U.S. operators, Green Thumb's robust financials position it as a credible contender to follow Trulieve into the NYSE. While an official listing date remains undetermined, Green Thumb's profile, financial strength, and strategic position make it a compelling candidate for the next cannabis stock to be listed on Wall Street.

Written by urgent.news from Motley Fool's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at fool.com →

More in Finance & Markets

More from Friday 20 November →